US-based contract research organisation WCCT Global has expanded its support services in ophthalmic medicine and science by acquiring OC Clinical Trials & Consulting in Santa Ana, California for an undisclosed sum.
The acquisition brings to WCCT research capabilities spanning glaucoma, oculoplastics, cosmetic clinical research, corneal and external ocular disease, and paediatric ophthalmic conditions at two sites in Tustin, California.
These include an ophthalmology research facility in close proximity to WCCT Global’s existing clinical pharmacology units in Orange County, Southern California.
According to WCCT, the acquisition fits its vision of offering innovative service options to clients in the form of designated research and patient-care facilities for both early- and late phase clinical research across multiple specialty therapeutic areas.
“The strategic placement of each of our five California research facilities offering unique therapeutic research services enables WCCT Global to provide both patient access and expert therapeutic knowledge and experience for each clinical study that we carry out on behalf of our sponsors,” commented chief operating officer Jon Rojas.
